FISCHER · NSE

Fischer Medical Ventures Limited

₹33.15

-0.45% (-₹0.15)

Prev. close

₹33.3

Volume

3,61,136

Delivery %

57.4%

As of

18 Sept 2026

Price history

₹33.15+₹1.33 (+4.18%) · 3M
10 Jun 202618 Sept 2026
₹41.72₹31.8210 Jun03 Jul03 Aug26 Aug18 Sept
Daily closes · updates after each session

No analyst calls on this stock in the last 90 days yet.

Explore by date range →

Analyst opinions

No analyst calls on Fischer Medical Ventures Limited in the last 90 days.

Fundamentals

About Fischer Medical Ventures Limited

Fischer Medical Ventures Limited engages in the manufacture, distribution, leasing, and maintenance of medical equipment in India and internationally. Its product portfolio includes magnetic resonance imaging (MRI) systems; preventive health kiosks; e-health access points; software solutions; cancer, TB screening, and handheld x-ray; spincare technology; nutraceuticals; mental health solutions; contactless screening solutions; and CT scan systems, as well as preventive diagnostic devices and ancillary medical instruments. The company was formerly known as Fischer Chemic Limited and changed its name to Fischer Medical Ventures Limited in March 2024. Fischer Medical Ventures Limited was incorporated in 1993 and is headquartered in Chennai, India.

Details

Sector

Healthcare

Industry

Medical Devices

CEO

Mr. Ravindran Govindan LLB

Headquarters

Chennai

Employees

16

Key stats

Market cap

₹2,268.81 Cr

P/E ratio (TTM)

73.7

Dividend yield

0.15%

EPS (TTM)

₹0.45

Beta (1Y · daily vs NIFTY 50)

0.59

Shares float

12.82 Cr

EPS · quarter ended Jun 2026

₹0.05

Financial Performance

01 · Financials

0 Cr100 Cr200 Cr300 Cr400 Cr0%5000%10000%15000%FY21FY22FY23FY24FY25FY26
RevenueRevenue growth YoY

FY21 growth needs FY20 filings, which the data source doesn't provide. Net income and EBITDA are omitted from this chart: coverage begins inside the plotted window, and every plotted period must carry a complete point set — the P&L table below has the available figures.

02 · Earnings Per Share (EPS)

-1012FY23FY24FY25FY26

03 · Dividend Profile

00000%0%0%0%22 Sept 25
Dividend (₹/share)Annualised yield

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based

0%5000%10000%15000%FY24FY25FY26
SalesFixed assetsTrade receivablesInventory

05 · Capital Structure & Asset Utilization

0 Cr250 Cr500 Cr750 Cr20×40×60×80×FY21FY22FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Debt/equity omitted where reported equity was zero or negative. Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

0 Cr250 Cr500 Cr750 CrFY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

Other assets floored at zero for years where fixed and current assets exceeded reported total assets.

07 · Debt Level & Coverage

-200 Cr-100 Cr0 Cr100 Cr200 CrFY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹17.95 L₹20.98 Cr₹110.70 Cr₹308.58 Cr
EBITDA₹1.52 L₹2.36 Cr₹4.74 Cr₹54.66 Cr
₹-3.65 L₹1.84 Cr₹1.48 Cr₹32.21 Cr
Diluted EPS₹-0.21₹1.08₹0.01₹0.45

Revenue, Total expenses (as filed), Employee benefit expense, Depreciation & amortisation, Other expenses, EBITDA, Net income, Pretax income, Tax provision, Interest expense, Other income, Diluted EPS have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹25.36 L₹19.03 L₹0₹86.00 Cr₹457.00 Cr₹672.00 Cr
₹23.28 L₹38.92 L₹57.17 L₹1.68 Cr₹85.37 Cr₹107.08 Cr
Stockholders' equity₹31,000₹-22.95 L₹17.00 L₹82.00 Cr₹338.00 Cr₹384.00 Cr

Trade receivables, Fixed assets, CWIP, Others, Long-term debt, Current (short-term) debt have filed figures for only some of the years shown — the missing years are left blank rather than estimated. Inventory shows ₹0 for 2023-03-31 — this deck's own annual-report reading has no Inventory figure for this filer in any year shown (2023-03-31, 2021-03-31, 2022-03-31 alike); the ₹0 shown here comes from this filer's own reported data feed rather than this deck's own extraction, and is positively consistent with a filer that holds no physical inventory (typical for lenders and other financial-services companies) rather than a display default. 2021-03-31, 2022-03-31 have no Inventory figure reaching this deck at all — not shown as zero, not shown as positive — left blank rather than assumed to match the other years.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹-14.59 L₹-7.35 Cr₹-86.25 Cr₹-101.27 Cr
Investing cash flow₹0₹-31.39 Cr₹-125.36 Cr₹-5.22 Cr
₹16.60 L₹37.06 Cr₹314.92 Cr₹14.11 Cr
Capital expenditure₹-48.49 L₹-5.99 Cr₹-1.31 Cr
End cash position₹3.58 L₹94.83 L₹104.26 Cr₹11.69 Cr

Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt issued, Debt repaid, Dividends paid, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

11 · Shareholding Pattern

NSE, quarterly

Line itemJun 25Dec 25(5Q)Mar 26Jun 26(2Q)Aug 26
Promoter61.80%62.15%63.08%
Public38.20%37.85%36.92%
Employee trusts0.00%0.00%0.00%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.48 L Cr₹1,837.337.05.3613.7%0.06+11.9%+11.4%
Divi's Laboratories Limited₹2.47 L Cr₹9,37583.314.7715.3%0.00+12.3%+53.4%
Torrent Pharmaceuticals Limited₹1.83 L Cr₹4,87576.921.8225.8%1.79+21.5%+37.4%
Apollo Hospitals Enterprise Limited₹1.26 L Cr₹8,944.560.413.3020.5%0.90+15.7%+13.9%
Lenskart Solutions Limited₹1.18 L Cr₹707.2179.913.485.6%0.35+35.4%
Zydus Lifesciences Limited₹1.13 L Cr₹1,16025.34.1818.6%0.46+18.4%+10.7%
Cipla Limited₹1.10 L Cr₹1,376.332.53.1911.3%0.02+2.1%-11.8%
Laurus Labs Limited₹1.05 L Cr₹1,95496.419.8616.8%0.48+22.0%+111.6%
Max Healthcare Institute Limited₹1.01 L Cr₹1,049.369.89.3913.4%0.32+19.0%-10.6%
Dr. Reddy's Laboratories Limited₹97,876.16 Cr₹1,18529.62.6011.4%0.21+3.2%-10.4%
Manipal Health Enterprises Limited₹97,364.22 Cr₹738.95146.611.567.8%1.53+18.0%
Fischer Medical Ventures Limited₹2,277.56 Cr₹33.1574.05.938.4%0.28+178.8%-70.9%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

Documents

Annual reports

Show all 26

Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.

FISCHER

Fischer Medical Ventures Q2 FY27 Preview

Univest · 6 days ago

FISCHER

Fischer Medical Ventures to Email FY26 Annual Report and Hold Virtual AGM

TipRanks · 15 days ago